Company logo

CORT - Corcept Therapeutics Incorporated

NASDAQ -> Healthcare -> Biotechnology
Menlo Park, United States
Type: Equity

CORT price evolution
CORT
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $135.55 $111.8 $172.38 $299.94
Short term investments $232.67 $243.43 $190.88 $165.12
Net receivables $41.12 $34.63 $32.55 $32.56
Inventory $15.97 $16.27 $15.68 $16.57
Total current assets $458.64 $431.53 $432.59 $533.89
Long term investments $57.18 $59.62
Property, plant & equipment $0.32 $0.48 $0.65 $1.04
Goodwill & intangible assets
Total noncurrent assets $162.88 $162.5 $92.04 $83.95
Total investments $289.85 $303.05 $190.88 $165.12
Total assets $621.52 $594.02 $524.63 $617.85
Current liabilities
Accounts payable $17.4 $16.71 $7.98 $11.22
Deferred revenue
Short long term debt $0.15 $0.23 $0.3 $0.57
Total current liabilities $104.5 $121.87 $93.06 $78.86
Long term debt
Total noncurrent liabilities $10.31 $10.47 $9.95 $9.4
Total debt $0.15 $0.23 $0.3 $0.57
Total liabilities $114.81 $132.34 $103.01 $88.26
Shareholders' equity
Retained earnings $402.53 $371.17 $339.79 $312.26
Other shareholder equity $0.61 -$0.23 $0.04 -$0.15
Total shareholder equity $506.7 $461.68 $421.61 $529.58
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $135.55 $66.33 $77.62 $76.19
Short term investments $232.67 $365.34 $145.92 $364.51
Net receivables $41.12 $31.06 $27.63 $26.2
Inventory $15.97 $6.1 $17.95 $21.16
Total current assets $458.64 $499.25 $266.46 $478.5
Long term investments $57.18 $4.95 $112.28 $36.2
Property, plant & equipment $0.32 $1.78 $1.52 $4.18
Goodwill & intangible assets
Total noncurrent assets $162.88 $84.18 $157.29 $93.23
Total investments $289.85 $370.29 $258.19 $400.7
Total assets $621.52 $583.43 $423.76 $571.73
Current liabilities
Accounts payable $17.4 $11.98 $6.91 $10.55
Deferred revenue
Short long term debt $0.15 $1.14 $0.53 $2.05
Total current liabilities $104.5 $72.49 $47.54 $47.49
Long term debt $0.5
Total noncurrent liabilities $10.31 $9.1 $0.41 $0.9
Total debt $0.15 $1.14 $0.53 $2.55
Total liabilities $114.81 $81.59 $47.95 $48.39
Shareholders' equity
Retained earnings $402.53 $296.39 $194.97 $82.46
Other shareholder equity $0.61 -$0.87 -$0.23 $0.41
Total shareholder equity $506.7 $501.84 $375.81 $523.34
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $135.41 $123.6 $117.72 $105.65
Cost of revenue $1.88 $1.65 $1.57 $1.39
Gross Profit $133.53 $121.96 $116.14 $104.27
Operating activities
Research & development $54.71 $45.52 $43.28 $40.85
Selling, general & administrative $47.15 $45.26 $43.28 $48.56
Total operating expenses $101.86 $90.78 $86.56 $89.42
Operating income $31.67 $31.18 $29.58 $14.85
Income from continuing operations
EBIT $31.46 $30.97 $29.41 $14.78
Income tax expense $5.45 $5.01 $5.4 $2.56
Interest expense -$5.14 -$5.21 -$3.35 -$3.58
Net income
Net income $31.14 $31.17 $27.36 $15.81
Income (for common shares) $31.14 $31.17 $27.36 $15.81
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $482.38 $401.86 $365.98 $353.87
Cost of revenue $6.48 $5.38 $5.28 $5.58
Gross Profit $475.89 $396.47 $360.7 $348.29
Operating activities
Research & development $184.35 $130.99 $113.86 $114.76
Selling, general & administrative $184.26 $152.85 $122.36 $105.33
Total operating expenses $368.61 $283.84 $236.22 $220.09
Operating income $107.28 $112.63 $124.48 $128.2
Income from continuing operations
EBIT $106.64 $112.5 $124.48 $128.2
Income tax expense $18.42 $14.77 $12.49 $25.59
Interest expense -$17.27 -$3.56 -$0.53 -$3.4
Net income
Net income $105.5 $101.29 $112.51 $106.01
Income (for common shares) $105.5 $101.29 $112.51 $106.01
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income $31.14 $31.17 $27.36 $15.81
Operating activities
Depreciation $0.63 $0.17 $0.82 $0.74
Business acquisitions & disposals
Stock-based compensation $13.06 $12.88 $11.86 $11.14
Total cash flows from operations $5.89 $52.91 $42.29 $25.96
Investing activities
Capital expenditures -$0.04 -$0.1
Investments $17.1 -$109.53 -$24 $207.47
Total cash flows from investing $17.1 -$109.57 -$24.1 $207.47
Financing activities
Dividends paid
Sale and purchase of stock $0.77 -$3.92 -$145.75 $0.18
Net borrowings
Total cash flows from financing $0.77 -$3.92 -$145.75 $0.18
Effect of exchange rate
Change in cash and equivalents $23.75 -$60.58 -$127.56 $233.61
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income $105.5 $101.29 $112.51 $106.01
Operating activities
Depreciation $2.36 $2.97 $3.07 $2.24
Business acquisitions & disposals
Stock-based compensation $48.94 $42.44 $42.93 $33.54
Total cash flows from operations $127.04 $120.32 $167.89 $151.97
Investing activities
Capital expenditures -$0.14 -$0.41 -$0.47 -$1.24
Investments $91.05 -$113.91 $136.59 -$118.03
Total cash flows from investing $90.91 -$114.33 $136.13 -$119.26
Financing activities
Dividends paid
Sale and purchase of stock -$148.72 -$17.28 -$302.59 $12.21
Net borrowings
Total cash flows from financing -$148.72 -$17.28 -$302.59 $12.21
Effect of exchange rate
Change in cash and equivalents $69.22 -$11.29 $1.43 $44.92
Fundamentals
Market cap $2.62B
Enterprise value $2.48B
Shares outstanding 103.41M
Revenue $482.38M
EBITDA $108.98M
EBIT $106.62M
Net Income $105.48M
Revenue Q/Q 31.39%
Revenue Y/Y 20.04%
P/E ratio 24.82
EV/Sales 5.15
EV/EBITDA 22.78
EV/EBIT 23.29
P/S ratio 5.43
P/B ratio 5.17
Book/Share 4.89
Cash/Share 1.31
EPS $1.02
ROA 17.89%
ROE 21.98%
Debt/Equity 0.23
Net debt/EBITDA -0.19
Current ratio 4.39
Quick ratio 4.24